NIH Information Quality

Draft NTP Technical Report on Prenatal Developmental Toxicity Studies of Vinpocetine (CAS No. 42971-09-5) in Sprague Dawley (Hsd:Sprague Dawley SD) Rats and New Zealand White (Hra:NZW SPF Rabbits (Gavage Studies)

Document, Report, or Other Product Information
Title: Draft NTP Technical Report on Prenatal Developmental Toxicity Studies of Vinpocetine (CAS No. 42971-09-5) in Sprague Dawley (Hsd:Sprague Dawley SD) Rats and New Zealand White (Hra:NZW SPF Rabbits (Gavage Studies)
Subject: The National Toxicology Program (NTP) has conducted prenatal developmental toxicology studies in rodents of vinpocetine. Vipocetine is a man-made chemical marketed in the United States as a dietary supplement for enhanced learning, memory, and cognition and in other countries as a pharmaceutical drug. These studies were conducted to determine if there is potential harm to the developing fetus.
Purpose (e.g., abstract): This draft report will be peer reviewed by an external scientific panel. Information about the peer review will be posted to the NTP website by June 5, 2019.
Information Product Contact
ISI or HISA: ISI
Link to Information Product:
IC: NIEHS
IC Division, Office, or Program: Division of the National Toxicology Program
NIH Contact: Mary Wolfe
919-541-7539
[email protected]
Reviewer Names and Expertise:
Review Description: An external scientific panel will meet at NIEHS to peer review the draft report.
Date of Review: 2019-07-31
Number of Reviewers: 6
Reviewer Nominations Requested?
Upcoming Panels, Events: View Upcoming Panels, Events, Notices, Meeting Updates
Technical/Draft Reports, Public Comments and Presentations: https://ntp.niehs.nih.gov/go/36051
Past Roster, Notices, Meeting Updates: View Past Roster, Notices, Meeting Updates
Reviewer Expertise: general toxicology, reproductive and developmental toxicology
How Selected: NTP selected from identified experts
Opportunity for Public Comment? YES
Did any reviewers require any exception to the applicable independence or COI standards of the Bulletin, including determination by the Sec./Dep. Sec. pursuant to Section (3)(c)?
Were any waivers, deferrals, exemptions, or alterative peer review processes used?
Any Public Meetings?
Number of Public Comments Received
This page last reviewed on